Peter Lamptey, President of Public Health Programs at FHI 360, discusses the link between HIV and non-communicable diseases (NCDs) and why FHI 360 is investing in developing platforms to help manage the burden of NCDs.
No Responses
More From This Series
-
Who Gets the HAART? Policy Implications for a Limited Resource
The rapid scale up of highly active antiretroviral therapy (HAART) for HIV infection has been a global health success. On World AIDS Day (December 1, 2011), UNAIDSestimates we currently have 6.6 million HIV-infected people on antiretroviral agents (ARV), a number that was inconceivable less than...
Read More -
FHI 360’s HIV/AIDS Work in Action
For the last 30 years, FHI 360 has been committed to addressing the impact of HIV/AIDS in all corners of the world through solid research and innovative programs...
Read More -
Visioning the End of AIDS
During the past few years, the world has made remarkable progress toward defeating the HIV epidemic. According to reports from the Joint United Nations Programme on HIV/AIDS (UNAIDS), new HIV infections have dropped 21 percent since 1997 and deaths from AIDS-related illnesses have decreased by 21...
Read More -
HPTN 052 Study: Implications for Treatment as Prevention
Leading up to World AIDS Day, there have been rallying calls to scale up HIV prevention and treatment services around the world. When it comes to treatment as prevention, there is little doubt that the HIV Prevention Trials Network (HPTN) 052 study has played an important role in furthering our...
Read More -
Magic’s HIV Announcement (20 years ago)
Recently, I was reminded that my research on HIV started 20 years ago and at the time, I didn’t know it. November 7th, 1991 was the day that Magic Johnson announced that he was/is HIV positive...
Read More